Immunization after the elective end of antineoplastic chemotherapy in children

Francesca Fioredda, Michaela Cavillo, Laura Banov, Alessandro Plebani, Anna Timitilli, Elio Castagnola

Research output: Contribution to journalArticlepeer-review


The aim of the present commentary is to discuss the multifaceted topic of vaccinations after treatment for cancer in the pediatric age. Publications in this field reveal conflicting data and opinions; no evidence-based guidelines currently exist. However, in spite of several discrepancies some commonly accepted information and conclusions exist. Efforts to find a common strategy of re-immunization should be directed towards setting up prospective studies on sufficient numbers of patients to obtain statistically relevant end points.

Original languageEnglish
Pages (from-to)165-168
Number of pages4
JournalPediatric Blood and Cancer
Issue number2
Publication statusPublished - Feb 2009


  • Residual immunity after cancer
  • Vaccination after chemotherapy
  • Vaccination strategy

ASJC Scopus subject areas

  • Medicine(all)
  • Hematology
  • Oncology
  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Immunization after the elective end of antineoplastic chemotherapy in children'. Together they form a unique fingerprint.

Cite this